- Home
- ACHC vs RXRX Comparison
ACHC vs RXRX Comparison
Compare ACHC & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHC
- RXRX
- Stock Information
- Founded
- ACHC 2005
- RXRX 2013
- Country
- ACHC United States
- RXRX United States
- Employees
- ACHC N/A
- RXRX N/A
- Industry
- ACHC Medical Specialities
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- ACHC Health Care
- RXRX Health Care
- Exchange
- ACHC Nasdaq
- RXRX Nasdaq
- Market Cap
- ACHC 1.7B
- RXRX 2.4B
- IPO Year
- ACHC N/A
- RXRX 2021
- Fundamental
- Price
- ACHC $19.24
- RXRX $5.36
- Analyst Decision
- ACHC Strong Buy
- RXRX Buy
- Analyst Count
- ACHC 9
- RXRX 5
- Target Price
- ACHC $47.50
- RXRX $7.00
- AVG Volume (30 Days)
- ACHC 2.1M
- RXRX 28.1M
- Earning Date
- ACHC 08-05-2025
- RXRX 08-05-2025
- Dividend Yield
- ACHC N/A
- RXRX N/A
- EPS Growth
- ACHC N/A
- RXRX N/A
- EPS
- ACHC 1.52
- RXRX N/A
- Revenue
- ACHC $3,229,609,000.00
- RXRX $64,596,000.00
- Revenue This Year
- ACHC $7.80
- RXRX $19.96
- Revenue Next Year
- ACHC $8.56
- RXRX $61.39
- P/E Ratio
- ACHC $12.64
- RXRX N/A
- Revenue Growth
- ACHC 5.64
- RXRX 30.14
- 52 Week Low
- ACHC $17.13
- RXRX $3.79
- 52 Week High
- ACHC $82.41
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- ACHC 37.45
- RXRX 43.96
- Support Level
- ACHC $17.13
- RXRX $5.28
- Resistance Level
- ACHC $22.51
- RXRX $5.69
- Average True Range (ATR)
- ACHC 1.22
- RXRX 0.41
- MACD
- ACHC -0.40
- RXRX -0.12
- Stochastic Oscillator
- ACHC 35.17
- RXRX 4.30
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.